Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
GRAIL Stock Price, Quotes and Forecasts | NASDAQ:GRAL | Benzinga
Explore GRAIL stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GRAL.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GRAIL (GRAL) stock?
You can purchase shares of GRAIL (NASDAQ:GRAL) through any online brokerage.
Who are GRAIL (GRAL) competitors?
Other companies in GRAIL’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and Centessa Pharmaceuticals (NASDAQ:CNTA).
What is the forecast, or price target, for GRAIL (GRAL) stock?
GRAIL has a consensus price target of $26.00.
What is the current price for GRAIL (GRAL)?
The stock price for GRAIL (NASDAQ: GRAL) is $36.545 last updated May 8, 2025 at 12:06 PM EDT.
Does GRAIL (GRAL) pay a dividend?
There are no upcoming dividends for GRAIL.
When is GRAIL (NASDAQ:GRAL) reporting earnings?
GRAIL’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is GRAIL (GRAL) going to split?
There is no upcoming split for GRAIL.
What sector and industry does GRAIL (GRAL) operate in?
GRAIL is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
